Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 1/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9059244 | 0.81 | FABP3 (0.40) | FABP3FABP4FABP5ENPP3ENPP1 | |
| SCHEMBL8941659 | 0.77 | SOAT1 (0.35) | FABP3FABP4FABP5SOAT1 | |
| SCHEMBL11888501 | 0.72 | FABP4 (0.55) | FABP3FABP4FABP5ENPP3ENPP1 | |
| SCHEMBL17639907 | 0.67 | FABP4 (0.57) | FABP3FABP4FABP5ENPP3ENPP1 | |
| SCHEMBL15082948 | 0.66 | FABP4 (0.51) | FABP3FABP4FABP5ENPP3ENPP1 | |
| SCHEMBL592480 | 0.66 | FABP3 (0.64) | FABP3FABP4FABP5 | |
| Tetrabuthylammonium SCHEMBL592617 | 0.65 | FABP4 (0.68) | FABP3FABP4FABP5 | |
| SCHEMBL2946584 | 0.65 | FABP4 (0.62) | FABP3FABP4FABP5ENPP3ENPP1 | |
| SCHEMBL11889235 | 0.65 | FABP4 (0.62) | FABP3FABP4FABP5 | |
| SCHEMBL20464065 | 0.65 | FABP4 (0.49) | FABP3FABP4FABP5ENPP3ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5510379-A | USEFUL FOR TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1996-04-23 | — | — | US | disclosed |